Ghayyor Ahmad

Ghayyor Ahmad

Auto-generated profile, based on publicly available information

Ghayyor Ahmad

Department of Human Genetics & Molecular Biology, Division of Basic Medical Sciences, University of Health Sciences, Lahore, Pakistan

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in Shock
Verified
Journal Article
Closed access
SSSadaf Sultan
Sadaf Sultan
MPMatteo Pascucci
Matteo Pascucci
SAShakil Ahmad
Shakil Ahmad
IMIhtzaz Ahmad Malik
Ihtzaz Ahmad Malik
ABAlberto Bianchi
Alberto Bianchi
GRGiuliano Ramadori
Giuliano Ramadori
Lipocalin-2 (LCN-2) is a 25-kDa secretory protein currently used as a biomarker for renal injury and inflammation. Its source and cause of the increased serum levels are unclear. The current study compares LCN-2 gene expression with known major acute-phase proteins in the liver in a rat and mouse model of turpentine oil-induced sterile abscess. Serum LCN-2 concentrations increased dramatically up to 200-fold (20 μg/mL) at 48 h after turpentine oil injection. A strong elevation of LCN-2 mRNA in rat liver was observed starting from 4 h up to 48 h after injection, with a maximum (8,738 ± 2,104-fold) at 24 h, which was further confirmed by Western blot analysis. In contrast, the increases in gene expression of α₂-macroglobulin, the major acute-phase protein, and hemoxygenase 1, a positive acute-phase protein, were only 1,025 ± 505-fold and 47 ± 12-fold, respectively, during acute-phase reaction (APR). No considerable change was observed in LCN-2 mRNA in rat kidney and other organs as compared with liver. Using wild-type mice, a massive increase in gene expression of LCN-2, with a maximum of 2,498 ± 84-fold in liver, which is similar to that for serum amyloid A (2,825 ± 233-fold), a major mouse acute-phase protein. However, such an increase was significantly inhibited in interleukin 6 knockout mice during APR. Interleukin 6-treated rat hepatocytes induced a significant time-dependent upregulation of LCN-2.Lipocalin-2 is the major acute-phase protein in rat as compared with α₂-macroglobulin and hemoxygenase 1 and comparable with serum amyloid A in mouse whose gene expression is mainly controlled by interleukin 6. The liver is the main source of serum LCN-2 in the case of APR. ABBREVIATIONS-LCN-2-lipocalin-2-α₂M-α₂-macroglobulin-HO-1-hemoxygenase 1-IL-6-interleukin 6-SAA-serum amyloid A-TO-turpentine oil-APR-acute-phase reaction.

1 September 2010 in Laboratory Investigation
Verified
Journal Article
Closed access
PRPierluigi Ramadori
Pierluigi Ramadori
GAGhayyor Ahmad
Ghayyor Ahmad
Giuliano RamadoriGiuliano Ramadori
Giuliano Ramadori

1 November 2009 in Laboratory Investigation
Verified
Journal Article
Closed access
FMFederico Moriconi
Federico Moriconi
GAGhayyor Ahmad
Ghayyor Ahmad
PRPierluigi Ramadori
Pierluigi Ramadori
IMIhtzaz Malik
Ihtzaz Malik
NSNadeem Sheikh
Nadeem Sheikh
GRGiuliano Ramadori
Giuliano Ramadori

1 July 2009 in Strahlentherapie und Onkologie
Verified
Journal Article
Closed access
PDF file
FMFederico Moriconi
Federico Moriconi
IMIhtzaz Malik
Ihtzaz Malik
GAGhayyor Ahmad
Ghayyor Ahmad
Jozsef DudasJozsef Dudas
Jozsef Dudas
MRMargret Rave-Fränk
Margret Rave-Fränk
HCHans Christiansen
Hans Christiansen

1 April 2014 in Shock
Verified
Journal Article
Closed access
SAShakil Ahmad
Shakil Ahmad
SSSadaf Sultan
Sadaf Sultan
NNNaila Naz
Naila Naz
GAGhayyor Ahmad
Ghayyor Ahmad
SASalamah Mohammad Alwahsh
Salamah Mohammad Alwahsh
IMIhtzaz Malik
Ihtzaz Malik
Decreased serum and increased hepatic iron uptake is the hallmark of acute-phase (AP) response. Iron uptake is controlled by iron transport proteins such as transferrin receptors (TfRs) and lipocalin 2 (LCN-2). The current study aimed to understand the regulation of iron uptake in primary culture hepatocytes in the presence/absence of AP mediators. Rat hepatocytes were stimulated with different concentrations of iron alone (0.01, 0.1, 0.5 mM) and AP cytokines (interleukin 6 [IL-6], IL-1β, tumor necrosis factor α) in the presence/absence of iron (FeCl3: 0.1 mM). Hepatocytes were harvested at different time points (0, 6, 12, 24 h). Total mRNA and proteins were extracted for reverse transcriptase–polymerase chain reaction (RT-PCR) and Western blot. A significant iron uptake was detected with 0.1 mM iron administration with a maximum (133.37 ± 4.82 µg/g of protein) at 24 h compared with control and other iron concentrations. This uptake was further enhanced in the presence of AP cytokines with a maximum iron uptake (481 ± 25.81 µg/g of protein) after concomitant administration of IL-6 + iron to cultured hepatocytes. Concomitantly, gene expression of LCN-2 and ferritin subunits (light- and heavy-chain ferritin subunits) was upregulated by iron or/and AP cytokines with a maximum at 24 h both at mRNA and protein levels. In contrast, a decreased TfR1 level was detected by IL-6 and iron alone, whereas combination of iron and AP cytokines (mainly IL-6) abrogated the downregulation of TfR1. An increase in LCN-2 release into the supernatant of cultured hepatocytes was observed after addition of iron/AP cytokines into the medium. This increase in secretion was further enhanced by combination of IL-6 + iron. In conclusion, iron uptake is tightly controlled by already present iron concentration in the culture. This uptake can be further enhanced by AP cytokines, mainly by IL-6.

1 January 2010 in Liver International
Verified
Journal Article
Closed access
PDF file
PRPierluigi Ramadori
Pierluigi Ramadori
NSNadeem Sheikh
Nadeem Sheikh
GAGhayyor Ahmad
Ghayyor Ahmad
Jozsef DudasJozsef Dudas
Jozsef Dudas
Giuliano RamadoriGiuliano Ramadori
Giuliano Ramadori